Enterprise Europe Network

MEDICA Healthcare Brokerage Event 2026

16 – 29 Nov 2026 | Düsseldorf, Germany

Register
Register
Register

InvestmentUpdated on 14 October 2026

Looking for co-investment in seed stage in the area of quantitative POCT diagnostics for human and veterinary health

Owner of CSICC and CIO of CENIOS GmbH at CSICC - Carmona-Schneider International Cooperation Consulting and CENIOS GmbH

Bochum, Germany

About

CENIOS is a deep-tech start-up specialising in nanodiagnostics and rapid, quantitative point-of-care tests (POCT).

What we do:

  • Detect analytes such as cytostatics, antibiotics, toxins, and pesticides

  • Develop applications for human and veterinary medicine, food safety, and environmental analysis

  • Provide faster and more affordable tests than existing solutions

  • Develop a dedicated reader for on-site testing

Our patented technology delivers fast, reliable, quantitative results at the point of need. It supports healthcare professionals, laboratories, and other users in making informed decisions and providing personalised treatment. Applications include the detection of toxins, anti-cytostatics, and antibiotic residues, as well as food-safety testing for dairy and meat products.

We are seeking seed investment to launch production, complete certification, drive marketing, and establish a broad distribution network.

https://cenios.de/en/start/

Stage

  • Seed and Development
  • Growth and Establishment

Applies to

  • LIFE SCIENCE
  • MEDICINE

Organisation

Similar opportunities